Clinical Trials

Showing 461 - 480 of 493 trials
Title Investigatorsort icon Disease(s)
The Prevention of Delirium and Complications Associated with Surgical Treatments (PODCAST) Clinical Trial
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-240]
Veselis, Robert
  • Psychiatry & Behavioral Sciences
  • Quality of Life
A Phase I/II Study of Pazopanib plus MK-3475 (Pembrolizumab) in Patients with Previously Untreated, Inoperable Advanced Kidney Cancer
[Protocol 14-074]
Voss, Martin
  • Kidney Cancer
A Phase II Study of Axitinib plus Dalantercept or Placebo for Patients with Metastatic Kidney Cancer
[Protocol 12-255]
Voss, Martin
  • Kidney Cancer
A Phase I Study of Nivolumab in Combination with Sunitinib, Pazopanib, or Ipilimumab in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147]
Voss, Martin
  • Kidney Cancer
A Phase II Study of SNX-5422 in Patients with Select Advanced HER2 Cancers
[Protocol 13-112]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase I Study of INK128 (MLN0128) in Patients with Advanced Kidney, Bladder, or Endometrial Cancer
[Protocol 13-118]
Voss, Martin
  • Bladder Cancer
  • Kidney Cancer
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin
  • Bladder Cancer
  • Breast Cancer
  • Head & Neck Cancer
  • Lung Cancer, Non-Small Cell
    • Other
  • Lung Cancer, Small Cell
  • Solid Tumors
  • Upper Gastrointestinal
    • Gastric Cancer
  • Uterine (Endometrial) Cancer
A Phase Ib Study of MDX-1106 (BMS-936558 or Nivolumab) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155]
Wolchok, Jedd
  • Melanoma
A Study of the Biologic Effects of Nivolumab (BMS-936558) in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231]
Wolchok, Jedd
  • Melanoma
A Phase II Study of Whole-Lung IMRT in Children and Adults with Synovial Sarcoma that Spread to the Lungs
[Protocol 14-075]
Wolden, Suzanne
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase Ib/II Study of LGX818 and Cetuximab with or without BYL719 in Patients with BRAF-Mutant Metastatic Colorectal Cancer
[Protocol 14-019]
Yaeger, Rona
  • Colorectal Cancer
A Phase Ib/II Study of MEK162 plus Panitumumab in Patients with Metastatic Colorectal Cancer
[Protocol 14-044]
Yaeger, Rona
  • Colorectal Cancer
A Pilot Study of Image-Guided Navigation for High-Dose Rate Brachytherapy to Manage Discomfort in Patients with Previously Treated Spine Tumors
[Protocol 12-260]
Yamada, Yoshiya
  • Spine Tumors
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
Relapsed/Refractory
[Protocol 13-045]
Younes, Anas
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Ibrutinib (PCI-32765) plus R-CHOP Chemotherapy in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL)
[Protocol 13-146]
Younes, Anas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of CPI-0610 in Patients with Progressive Lymphoma
Relapsed/Refractory
[Protocol 13-259]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of Nivolumab in Patients with Classical Hodgkin Lymphoma that Has Returned After Autologous Stem Cell Transplantation
[Protocol 14-147]
Younes, Anas
  • Lymphoma
    • Hodgkin's Disease
A Phase I Study of CB-839 in Patients with Advanced or Persistent Hematologic Cancers
[Protocol 14-053]
Younes, Anas
  • Hematology
    • Hematologic Malignancies
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229]
Young, James
  • Melanoma